My experience with public companies is that they do not put out any news while negotiating with bankers and financing. So right now, IMO, no news is good news here. If you understand the company and the path it chose, and you agree, you are more likely to hold. If you have the day trade, big hit overnight mentality, this must be torture for you. Most everyone here is use to trading (and in this stock selling) on news. Not one release over the last 2 months saw a rise in the stock. IMO, each release provided a hint as to direction, and confirmed that the company is heading in that direction. Some are looking for organic growth, and unfortunately, if that were the case, in these markets with these products, it would take years and millions as well to develop. Serious non-dilutive money takes time to secure, because the bankers first need to qualify and confirm every single aspect of the company. They test the products, review the debt structure, examine and qualify the intellectual property, get their own counsel and accounting opinion letters and appraisals, and most import, they start showing the company internally to some of their biggest investors to see whether or not to take a company on, especially.......an OTC company, which I am SURE they normally DON'T want to take unless there is a bigger plan for it, its clean, and it completely checks out.
No sophisticated banking group will look at a presentation and write a check, certainly not in this environment, and certainly not for millions of dollars. It takes weeks, if not months to go through that process. I feel this company is unlike almost every single other company you may have invested in. It is for me anyway. While others can disagree on how they did things, I feel that they have done things knowing what will be required to pass the bankers tests for real non-dilutive money. Rome wasn't built in a day, but it certainly didn't need Brutus stabbing it in the back either.
